ANXA8 and breast carcinoma: Elegant studies were conducted to monitor ANXA8 upregulation during mouse mammary gland development and involution [116], as well as in a large group of patients with breast cancer [117] and in subpopulations with transiently quiescent c-kit positive luminal cells of the ductal mammary epithelium [118].